Drug profile · INN
cefotaxime sodium
CEFOTAXIME SODIUM
cefotaxime sodium (CEFOTAXIME SODIUM) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — cefotaxime sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 5
- Data quality
- 0.84
Quick answer
cefotaxime sodium (CEFOTAXIME SODIUM) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial penicillin-binding protein inhibitor
Primary target: Bacterial penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is cefotaxime sodium?
cefotaxime sodium (CEFOTAXIME SODIUM) is a bacterial penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for cefotaxime sodium?
CEFOTAXIME SODIUM is a marketed brand name for cefotaxime sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of cefotaxime sodium?
cefotaxime sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.